Skip to content

Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00165412
Enrollment
148
Registered
2005-09-14
Start date
2005-07-31
Completion date
2010-05-31
Last updated
2019-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Hodgkin's Disease

Keywords

Breast screening, Breast MRI, Mammogram, Mammography

Brief summary

The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.

Detailed description

* The screening breast MRI and mammography will be performed 6 months or longer after the last mammogram. For pre-menopausal women, the screening will be performed during the second week of the menstrual cycle to reduce cycle-related breast changes. As much as possible, the breast MRI and mammogram are to be performed on the same day. * On the day of the breast imaging studies, the patient will also be asked to fill out a baseline breast health questionnaire, which includes questions on time since radiation therapy, prior screening history, history of prior benign breast biopsies, menopausal status, prior hormonal therapy use, etc. * In patients with suspicious findings or findings highly suggestive of malignancy, the abnormal findings will be reviewed with the patient and recommendations will be made for a biopsy.

Interventions

PROCEDUREbreast MRI

Repeated once a year for three years

PROCEDUREMammogram

Repeated once a year for three years

Sponsors

Brigham and Women's Hospital
CollaboratorOTHER
Beth Israel Deaconess Medical Center
CollaboratorOTHER
Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female patients treated with radiation therapy to the chest area for Hodgkin's disease * Age between 12 and 35 at initial treatment * Eight years or longer after initial treatment * Pre-approval from the participant's insurance company for the breast imaging studies

Exclusion criteria

* Pregnant or lactating women * Post Bilateral mastectomy * Currently undergoing breast cancer therapy * Known metastatic cancer * Patients with contraindications for undergoing an MRI: cardiac pacemaker, known metallic objects in body e.g. metallic clips, bullets, shrapnel or buckshots.

Design outcomes

Primary

MeasureTime frame
To compare the sensitivity, specificity, positive and negative predictive value of mammography and breast MRI for breast cancer detection in women treated for Hodgkin's disease.5 years

Secondary

MeasureTime frame
To describe the MRI appearance and enhancing characteristics of breast cancer after Hodgkin's disease5 years
to correlate the breast MRI findings and pathological findings5 years
to determine the incidence of interval breast cancer in the screened population.5 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026